• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较腹膜癌病评分方法在预测晚期卵巢癌可切除性和预后中的作用。

Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.

机构信息

Department of Gynecology-Obstetrics and Prediction Unit (INSERM U953, Epidemiological Research Unit on Perinatal and Women's Health), Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, and CancerEst, Université Pierre et Marie Curie, Paris, France.

出版信息

Am J Obstet Gynecol. 2010 Feb;202(2):178.e1-178.e10. doi: 10.1016/j.ajog.2009.10.856.

DOI:10.1016/j.ajog.2009.10.856
PMID:20113693
Abstract

OBJECTIVE

The aim of this study was to compare carcinomatosis scores, and to determine their relevance to predict resectability, morbidity, and outcome.

STUDY DESIGN

From 2005-2008, 61 patients underwent surgery for ovarian cancer. We compared International Federation Gynecology and Obstetrics (FIGO), peritoneal cancer index, Eisenkop, Aletti, Fagotti, and Fagotti-modified scores.

RESULTS

There was a strong correlation between the different scores. In predicting resectability, Fagotti-modified and peritoneal cancer index outperformed other scores. We demonstrated a strong association between the occurrence of postoperative complications and Aletti, peritoneal cancer index, and Eisenkop scores (P < .0001). For progression-free survival, we observed significant differences among FIGO, peritoneal cancer index, Eisenkop, Fagotti-modified, and Aletti stages (P < .05). For stage III/IV patients, only Aletti score remains significant to predict resectability. This suggests that complete respectability is more related to the surgical effort than to the extent of the disease.

CONCLUSION

Alternative ranking systems provide additional information over FIGO for complete resectability, complications, and survival.

摘要

目的

本研究旨在比较癌转移评分,并确定其对预测可切除性、发病率和预后的相关性。

研究设计

2005 年至 2008 年,61 例卵巢癌患者接受了手术治疗。我们比较了国际妇产科联合会(FIGO)、腹膜癌指数、Eisenkop、Aletti、Fagotti 和 Fagotti 改良评分。

结果

不同评分之间存在很强的相关性。在预测可切除性方面,Fagotti 改良评分和腹膜癌指数优于其他评分。我们发现术后并发症的发生与 Aletti、腹膜癌指数和 Eisenkop 评分之间存在很强的关联(P<0.0001)。对于无进展生存期,我们观察到 FIGO、腹膜癌指数、Eisenkop、Fagotti 改良和 Aletti 分期之间存在显著差异(P<0.05)。对于 III/IV 期患者,只有 Aletti 评分仍然可以预测可切除性。这表明完全可切除性与手术难度更相关,而与疾病的严重程度无关。

结论

替代的分级系统在完全可切除性、并发症和生存率方面提供了比 FIGO 更多的信息。

相似文献

1
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.比较腹膜癌病评分方法在预测晚期卵巢癌可切除性和预后中的作用。
Am J Obstet Gynecol. 2010 Feb;202(2):178.e1-178.e10. doi: 10.1016/j.ajog.2009.10.856.
2
Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies.手助腹腔镜诊断妇科恶性肿瘤腹膜转移灶可切除性的准确性。
Eur J Surg Oncol. 2013 Jul;39(7):774-9. doi: 10.1016/j.ejso.2013.03.022. Epub 2013 Apr 16.
3
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer.晚期卵巢癌中腹膜癌评分方法在预测可切除性和预后方面的比较
Am J Obstet Gynecol. 2010 Sep;203(3):e10-1; author reply e11. doi: 10.1016/j.ajog.2010.04.037. Epub 2010 Jul 1.
4
[Advanced ovarian cancer: criteria of resectability].[晚期卵巢癌:可切除性标准]
Bull Cancer. 2009 Dec;96(12):1189-97. doi: 10.1684/bdc.2009.0985.
5
Surgery for recurrent ovarian cancer: role of peritoneal carcinomatosis: exploratory analysis of the DESKTOP I Trial about risk factors, surgical implications, and prognostic value of peritoneal carcinomatosis.复发性卵巢癌的手术治疗:腹膜癌的作用:关于腹膜癌危险因素、手术意义及预后价值的DESKTOP I试验探索性分析
Ann Surg Oncol. 2009 May;16(5):1324-30. doi: 10.1245/s10434-009-0357-0. Epub 2009 Feb 19.
6
External validation of a laparoscopic-based score to evaluate resectability of advanced ovarian cancers: clues for a simplified score.基于腹腔镜的评分系统对晚期卵巢癌可切除性评估的外部验证:简化评分的线索
Gynecol Oncol. 2008 Sep;110(3):354-9. doi: 10.1016/j.ygyno.2008.04.042. Epub 2008 Jun 24.
7
Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.手术细胞减灭术对IV期上皮性卵巢癌生存的影响。
Gynecol Oncol. 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145.
8
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.晚期卵巢癌积极的手术治疗与生存率的提高
Obstet Gynecol. 2006 Jan;107(1):77-85. doi: 10.1097/01.AOG.0000192407.04428.bb.
9
Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group).FIGO 分期 IV 期卵巢癌患者中残余肿瘤对结局的影响:AGO-OVAR(妇科肿瘤学卵巢癌研究组)的探索性分析。
Ann Surg Oncol. 2010 Jun;17(6):1642-8. doi: 10.1245/s10434-010-0964-9. Epub 2010 Feb 18.
10
Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer.根治性手术——腹膜切除术及术中腹腔内化疗用于复发性或原发性卵巢癌腹膜转移癌的治疗
J Surg Oncol. 2006 Sep 15;94(4):316-24. doi: 10.1002/jso.20597.

引用本文的文献

1
The Peritoneal Cancer Index as a Predictor of Cytoreductive Surgery Outcomes and Heatmapping of Ovarian Cancer Distribution: A Retrospective Analysis.腹膜癌指数作为细胞减灭术结果的预测指标及卵巢癌分布的热图分析:一项回顾性分析
Cancers (Basel). 2025 Aug 27;17(17):2790. doi: 10.3390/cancers17172790.
2
Therapeutic landscape of ovarian cancer: recent advances and emerging therapies.卵巢癌的治疗格局:最新进展与新兴疗法
Biomark Res. 2025 Aug 12;13(1):103. doi: 10.1186/s40364-025-00818-7.
3
PET/CT Volumetric Parameters as Predictors of the Peritoneal Cancer Index in Advanced Ovarian Cancer Patients.
PET/CT体积参数作为晚期卵巢癌患者腹膜癌指数的预测指标
Diagnostics (Basel). 2025 Jul 19;15(14):1818. doi: 10.3390/diagnostics15141818.
4
Potential Risks of Severe Infection Following the Exploratory Laparoscopy for Advanced Ovarian Cancer: A Case Report and a Literature Review.晚期卵巢癌腹腔镜探查术后严重感染的潜在风险:一例病例报告及文献综述
Cureus. 2024 Jul 26;16(7):e65415. doi: 10.7759/cureus.65415. eCollection 2024 Jul.
5
Assessment of Intraoperative Scoring Systems for Predicting Cytoreduction Outcome in Peritoneal Metastatic Disease: A Systematic Review and Meta-analysis.评估预测腹膜转移疾病细胞减灭术结局的术中评分系统:系统评价和荟萃分析。
Ann Surg Oncol. 2024 Oct;31(10):7165-7183. doi: 10.1245/s10434-024-15629-7. Epub 2024 Jun 25.
6
Exploring the Survival Determinants in Recurrent Ovarian Cancer: The Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.探索复发性卵巢癌的生存决定因素:细胞减灭术和腹腔内热化疗的作用。
Cancers (Basel). 2024 Jun 5;16(11):2150. doi: 10.3390/cancers16112150.
7
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor: A Single-Institution Experience (ID: PARROT Trial).腹腔内压力化疗(PIPAC)在铂耐药卵巢肿瘤复发中的应用:单中心经验(ID:PARROT 试验)。
Ann Surg Oncol. 2024 Feb;31(2):1207-1216. doi: 10.1245/s10434-023-14648-0. Epub 2023 Dec 15.
8
Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review.通过影像学和腹腔镜检查预测晚期卵巢癌的手术结果:一项叙述性综述
Cancers (Basel). 2023 Mar 22;15(6):1904. doi: 10.3390/cancers15061904.
9
Upfront surgery in patients with epithelial ovarian cancer and enlarged supradiaphragmatic lymph nodes associated with comparable to neoadjuvant chemotherapy.上皮性卵巢癌伴膈肌上肿大的淋巴结患者行 upfront 手术与新辅助化疗的疗效相当。
BMC Womens Health. 2022 Dec 19;22(1):531. doi: 10.1186/s12905-022-02082-5.
10
Prognostic influence of an early time to chemotherapy following primary cytoreductive surgery for advanced epithelial ovarian cancer.原发性细胞减灭术后早期化疗对晚期上皮性卵巢癌预后的影响。
J Gynecol Oncol. 2022 Nov;33(6):e80. doi: 10.3802/jgo.2022.33.e80. Epub 2022 Sep 8.